Statistics for Black Diamond Therapeutics (id:8404 BDTX)
Valuation metrics
Market cap
148.25M
Enterprise value
58.57M
Trailing P/E (ttm)
-1.35
Forward P/E
-2.15
PEG ratio
-2.15
Price/Sales (ttm)
Price/Book (mrq)
1.52
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.72
Overview
Shares outstanding
56.59M
Float
44.56M
Shares short
6.33M
% Held by insiders
0.02%
% Held by institutions
0.99%
Average volume (10 days)
491.80K
Average volume (90 days)
Price summary
52-Week low
2.16
52-Week high
7.66
52-Week change
11.81%
Beta
2.52
50-Day moving average
3.83
200-Day moving average
4.89
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-32.78%
Return on equity
-63.09%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-81,017,000.00
Net income to common (ttm)
-73,099,000.00
Diluted EPS (ttm)
-1.33
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
112.68M
Total cash per share (mrq)
1.99
Total debt (mrq)
23.00M
Total Debt/Equity (mrq)
23.61
Current ratio (mrq)
555.50%
Book value per share (mrq)
1.72
Cash flow
Cash flow statement
-61,204,000.00
Levered free cash flow (LFCF)
-34,594,624.00